Ampio Pharmaceuticals Inc (NYSE MKT LLC:AMPE)
| 5.02 Data as of Jan 30 |  -0.22 / -4.20%Today’s Change | 3.19 Today|||52-Week Range 9.36 | +46.36% Year-to-Date |
Latest AMPE News | Press Releases
| Ampio Pharmaceuticals (AMPE) Strong On High Relative Volume Today Jan 27 / TheStreet.com |
Today’s Trading
| Previous close | 5.24 |
| Today’s open | 5.10 |
| Day’s range | 5.00 - 5.33 |
| Volume | 711,575 |
| Average volume (3 months) | 565,060 |
| Market cap | $260.9M |
| Dividend yield | -- |
Data as of 4:05pm ET, 01/30/2015
Growth & Valuation
| Earnings growth (last year) | -85.29% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | 0.00% |
| P/E ratio | NM |
| Price/Sales | 5,460.76 |
| Price/Book | 6.37 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SNTASynta Pharmaceutical... | -0.09 | -3.64% |
| STMLStemline Therapeutic... | +0.49 | +3.27% |
| SVASinovac Biotech Ltd | +0.04 | +0.84% |
| CPRXCatalyst Pharmaceuti... | +0.23 | +6.73% |
Data as of 4:00pm ET, 01/30/2015
Financials
| Next reporting date | February 25, 2015 |
| EPS forecast (this quarter) | -$0.20 |
| Annual revenue (last year) | $50.0K |
| Annual profit (last year) | -$24.0M |
| Net profit margin | -48,017.12% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman & Chief Executive Officer Michael Macaluso |
Chief Operating Officer Joshua R. Disbrow |
Corporate headquarters Greenwood Village, Colorado |
Forecasts
.